Webinars
Learn from the best in healthcare. We present you with real-time developments and actionable strategies. Register to ask your immediate questions and to access our slides.
The Medicare Prescription Payment Plan: Impact to Part D Stakeholders in 2025
Join Avalere to learn about the new Medicare Prescription Payment Plan and what it means for Part D enrollees in 2025.
Part D Patient Access 2025: Drug Formulary Changes
Join Avalere experts to learn about the changes to Part D formularies for 2025 and implications for patient access.
Part D Patient Access 2025: Plan Options and Premiums
Avalere experts will examine changes in Part D plan options and premiums for 2025 and will explore how these shifts may affect patient costs and choice.
2026 Part D Plan and Manufacturer Contracting Strategies
Join our webinar to learn how Part D redesign and drug price negotiation will shape the Plan Year 2026 market, and what this means for manufacturers and plans.
Part D Patient Access 2025: Preparing for Benefit Changes
Join Avalere for an overview of how the Medicare Part D benefit will be changing in 2025 under the Inflation Reduction Act.
Exploring RNA-Based Therapies: Innovations and Impact
Join us for a webinar exploring the RNA-Based Therapy landscape.
Election 2024: What’s at Stake for Healthcare?
Experts from Avalere, part of Avalere Health, and guests discuss the 2024 elections, exploring the candidates’ health policy approaches and implications for stakeholders.
A Closer Look at Patient Support: Upcoming Legislative and Regulatory Changes
Avalere experts explore how potential implications of the Inflation Reduction Act (IRA)’s out-of-pocket cap, in addition to other key regulatory and policy activities shaping benefit design and patient cost-share (e.g., EHB), could impact patient commercial and foundation assistance.
Valuing the Patient Perspective: Patient-Centered HTA
This expert panel will address the challenge of integrating patient perspectives into value assessments, discussing implications for evidence strategy, health equity, caregiver involvement, and downstream impacts on care delivery.
Decoding the CY 2025 Advance Notice
Join Avalere’s healthcare policy experts as they dissect the Advance Notice of Methodological Changes for CY 2025 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies and discuss the future trajectory of Medicare Advantage (MA) in Part D and potential outcomes, headwinds, and tailwinds for health plans.
Part D Redesign’s Impact on Plan-Manufacturer Contracting
Avalere experts discussed how IRA’s Part D redesign may affect plan behavior in Plan Year 2025 and how manufacturers should approach contracting and market access.
Demystifying IRA Drug Price Negotiation
Avalere experts will explore the potential implications of the Inflation Reduction Act (IRA)’s Medicare drug price negotiation program guidance and discuss implementation strategies for the near- and long-term.
Preparing for Legislative Change and Connecting Equity and Outcomes
Join us for a live, expert discussion on life sciences industry trends to watch in Q4.
The Evolving Cell & Gene Therapy Market
Join Avalere’s panel of market access and policy experts for a discussion on the growing cell and gene therapy (CGT) pipeline, an in-depth look at the unique opportunities and challenges these novel therapies present, and an overview of the many hurdles stakeholders need to navigate for success.
Navigating Value-Based Care, Defining Value, and Drug Pricing Policy
Join Avalere for a live discussion on key trends in drug pricing, value, and regulatory shifts, and how these trends will impact manufacturers.
CMS Final Rate Announcement: How Should Plans Prepare?
Join Avalere’s healthcare policy experts for an analysis of the final rate announcement and a discussion on the future of Medicare Advantage (MA) and potential outcomes for health plans.
Avalere 2022 Healthcare Industry Outlook: Advance Your Opportunity
From policy and regulatory changes to COVID-19 and driving customer engagement, the healthcare environment continues to require healthcare stakeholders to adapt their strategies. How will you stay ahead of the trends impacting your business?
Achieving Readiness for Radioligand Therapy in the US
Join leading clinicians and experts for a discussion of new policy recommendations for improving radioligand therapy readiness in the US.
Driving Vaccine Access and Uptake
Join us for a live conversation exploring actionable strategies for driving greater vaccine access and adoption.
Post-Pandemic Planning for Life Sciences Companies
Avalere’s data analytics and market access experts will be joined by Jeff Patton, MD and CEO of OneOncology, to explore critical issues and considerations for life sciences stakeholders following the pandemic.